Universitätsmedizin der Johannes Gutenberg-Universität Mainz

Bioresorbable Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis (COMPARE-ABSORB trial): Very Late Device Thrombosis While on Extended DAPT (2019) Van Geuns RJ, Chang CC, Chevalier B, Gori T, Barbato E, Tarantini G, Achenbach S, et al. Conference contribution S2k-Leitlinie zur Therapie der Psoriasis bei Kindern und Jugendlichen - Kurzfassung Teil 2. (2019) Eisert L, Augustin M, Bach S, Dittmann M, Eiler R, Fölster-Holst R, Gerdes S, et al. Journal article Tumor immunoevasion by high glycolytic tumors through an acidosis-dependent induction of noninflammatory tumor-associated macrophages (2019) Bohn T, Rapp S, Pektor S, Gerlach K, Weigmann B, Lueckel C, Truong N, et al. Conference contribution Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine (2019) Schlenk RF, Weber D, Herr W, Wulf G, Salih HR, Derigs HG, Kuendgen A, et al. Journal article Limited Effect of Anti-PD-1 in advanced Skin Tumors of Patients with hemato-oncological Primary Disease: A retrospective multi-center Study of ADO (2019) Leiter-Stoeppke U, Loquai C, Meier F, Rafei-Shamsabadi D, Hassel J, Glutsch V, Sirokay J, et al. Conference contribution Association of an initial Exanthem with Vemurafenib and Cobimetinib for a better Therapeutic Success in metastatic Melanoma Patients (2019) Kaehler K, Bohne AS, Gutzmer R, Satzger I, Meier F, Reinhardt L, Zimmer L, et al. Conference contribution Changes in tears and ocular structures involved in tear film formation in chemotherapy-induced polyneuropathy in mice (2019) Welss J, Phunchago N, Sisignano M, Perumal N, Grus F, Feldt J, Lütjen-Drecoll E, Paulsen F Conference contribution Analytical and inter-observer comparability of 4 clinically developed programmed death-ligand 1 (PD-L1) immunohistochemistry assays in advanced clear cell renal cell carcinoma (CCRCC) (2019) Sommer U, Eckstein M, Ammann J, Braunschweig T, Macher-Goeppinger S, Schwamborn K, Hieke-Schulz S, et al. Conference contribution A Phase 2 Study of Galunisertib (TGF-beta 1 Receptor Type I Inhibitor) and Sorafenib in Patients With Advanced Hepatocellular Carcinoma (2019) Kelley RK, Gane E, Assenat E, Galle PR, Merle P, Hourmand IO, Cleverly A, et al. Journal article Major coronary evaginations following implantation of bioresorbable vascular scaffolds - Clinical and OCT characteristics (2019) Blachutzik F, Achenbach S, Röther J, Tröbs M, Schneider R, Nef H, Weissner M, et al. Journal article